AB 347 California Assembly · 2021-2022 Regular Session

Health care coverage: step therapy.

Summary
Existing law, the Knox-Keene Health Care Service Plan Act of 1975 (Knox-Keene) , provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law authorizes a health insurer to require step therapy if there is more than one drug that is appropriate for the treatment of a medical condition, and authorizes a health care service plan to utilize step therapy consistent with Knox-Keene. Under existing law, if a health care service plan, health insurer, or contracted physician group fails to respond to a completed prior authorization request from a prescribing provider within a specified timeframe, the prior authorization request is deemed to have been granted. This bill would clarify that a health care service plan that provides coverage for prescription drugs may require step therapy, as defined, if there is more than one drug that is clinically appropriate for the treatment of a medical condition. The bill would require a health care service plan or health insurer to expeditiously grant a step therapy exception request if the health care provider submits justification and supporting clinical documentation, as specified, supporting the provider's determination that the required prescription drug is inconsistent with good professional practice for provision of medically necessary covered services to the enrollee or insured, based on specified criteria. The bill would authorize a health care provider or prescribing provider to appeal a denial of an exception request for coverage of a nonformulary drug, prior authorization request, or step therapy exception request consistent with the health care service plan's or health insurer's current utilization management processes. The bill would authorize an enrollee or insured, or their designee or guardian, to appeal a denial of an exception request for coverage of a nonformulary drug, prior authorization request, or step therapy exception request, as specified. The bill would require a prior authorization or step therapy exception request to be deemed approved for the duration of the prescription, including refills, if a health care service plan, health insurer, or contracted physician group fails to send an approval or denial within a specified timeframe. Commencing January 1, 2022, the bill would require a contract between a health care service plan or health insurer and a utilization review organization that performs utilization review or utilization management functions on behalf of health care service plans or health insurers, or between a health care service plan and another contracted entity, to include terms that require the utilization review organization or other contracted entity to comply with specified provisions relating to step therapy determinations and procedures. Because a willful violation of the bill's requirements relative to health care service plans would be a crime, the bill would impose a state-mandated local program. The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason.
Bill status signed all 5 stages cleared
Introduction
Jan 2021
Committee Review
Aug 2021
Assembly Passage
Jun 2021
Senate Passage
Sep 2021
Signed into Law
Oct 2021
Introduced Jan 28, 2021 Signed Oct 9, 2021
Floor votes · Senate Sep 8, 2021 · Assembly Jun 2, 2021

How they voted

340
Passed · 3 other
Total votes 37
Sep 8, 2021
D Democratic29
26 Yea 3
89% Yea
R Republican8
8 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
29
Key actions
11
Committee
7
Amendments
12
Oct 9, 2021
Signed into law
Approved by the Governor.
legislature
Sep 9, 2021
Lower · Passed
Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 72. Noes 0. Page 3026.).
lower
Sep 8, 2021
Introduced
In Assembly. Concurrence in Senate amendments pending.
lower
Sep 8, 2021
Upper · Passed
Read third time. Passed. Ordered to the Assembly. (Ayes 37. Noes 0. Page 2498.).
upper
Sep 3, 2021
Upper · Passed
Read third time and amended. Ordered to second reading.
upper
Aug 26, 2021
Upper · Passed
Read second time and amended. Ordered returned to second reading.
upper
Aug 26, 2021
Introduced
From committee: Amend, and do pass as amended. (Ayes 5. Noes 1.) (August 26).
upper
Aug 16, 2021
Committee
In committee: Referred to suspense file.
upper
Jul 13, 2021
Upper · Passed
Read second time and amended. Re-referred to Com. on APPR.
upper
Jul 12, 2021
Introduced
From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 8. Noes 0.) (July 7).
upper
Jun 29, 2021
Introduced
From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH.
upper
Jun 28, 2021
Upper · Passed
In committee: Hearing postponed by committee.
upper
Jun 16, 2021
Committee
Referred to Com. on HEALTH.
upper
Jun 2, 2021
Lower · Passed
Read third time. Passed. Ordered to the Senate. (Ayes 69. Noes 1. Page 1841.)
lower
May 24, 2021
Lower · Passed
Read second time and amended. Ordered returned to second reading.
lower
May 20, 2021
Introduced
From committee: Amend, and do pass as amended. (Ayes 13. Noes 3.) (May 20).
lower
Apr 28, 2021
Committee
In committee: Set, first hearing. Referred to APPR. suspense file.
lower
Apr 12, 2021
Committee
Re-referred to Com. on APPR.
lower
Apr 8, 2021
Lower · Passed
Read second time and amended.
lower
Apr 7, 2021
Introduced
From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 13. Noes 1.) (April 6).
lower
Feb 12, 2021
Committee
Referred to Com. on HEALTH.
lower
Jan 29, 2021
Lower · Passed
From printer. May be heard in committee February 28.
lower
1 primary · 2 co-sponsors

Sponsors